XBI.MX SPDR Series Trust - SPDR S&P Biotech ETF
- Total assets
- 188B
- Expense ratio
- 0.35%
- Dividend yield
- 0.10%
- 1-year return
- +36.59%
- Holdings
- 10
- Since
- 2006
Fund data as reported by the issuer, updated Nov 7, 2026. Total assets are in the fund's base currency.
What does XBI.MX invest in?
Tracks Morningstar US Health TR USD- Mostly US stocks (100.4%)
- Largest sector: Healthcare (104.3%)
- Largest region: North America (94.9%)
- Top 3 holdings: 6.0% of the fund
Asset allocation
- US stocks 100.4%
- Non-US stocks 3.2%
Top holdings
- Moderna Inc 2.30%
- Natera Inc 1.87%
- Twist Bioscience Corp 1.81%
- Amgen Inc 1.80%
- Halozyme Therapeutics Inc 1.80%
SPDR Series Trust - SPDR S&P Biotech ETF performance
Sharpe ratio 0.91- This year
- +25.73%
- 1 year
- +36.59%
- 3 years
- +36.41%
- 5 years
- +0.36%
Volatility 25.4% over 1 year and 26.9% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
XBI.MX price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About SPDR Series Trust - SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Full fund profileSPDR Series Trust - SPDR S&P Biotech ETF top holdings
18.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 2.30% |
| Natera Inc NTRA.US | Healthcare | United States | 1.87% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 1.81% |
| Amgen Inc AMGN.US | Healthcare | United States | 1.80% |
| Halozyme Therapeutics Inc HALO.US | Healthcare | United States | 1.80% |
| Exelixis Inc EXEL.US | Healthcare | United States | 1.80% |
| Biogen Inc BIIB.US | Healthcare | United States | 1.76% |
| AbbVie Inc ABBV.US | Healthcare | United States | 1.75% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 1.70% |
| United Therapeutics Corporation UTHR.US | Healthcare | United States | 1.67% |
XBI.MX sector exposure
- Healthcare104.3%
- Financial Services0.5%
Share of the stocks in the fund.
XBI.MX regional exposure
- North America94.9%
- Europe Developed2.0%
- United Kingdom1.2%
Share of the stocks in the fund.
Company size
Average market cap 155B- Big cap10.0%
- Medium cap16.5%
- Small cap43.5%
- Micro cap29.0%
SPDR Series Trust - SPDR S&P Biotech ETF fund profile
- Fund name
- SPDR Series Trust - SPDR S&P Biotech ETF
- Ticker
- XBI.MX
- Exchange
- Mexican Exchange
- Index tracked
- Morningstar US Health TR USD
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Jan 31, 2006
- Trading currency
- MXN
- Expense ratio
- 0.35%
- Annual turnover
- 0.6%
About SPDR Series Trust - SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).